View the talks from the OpenRegulatory Conference 2021!

Updated September 30, 2021

Template: Post-Market Clinical Follow-Up Report (PMCFR)

Sven Piechottka
ISO 13485

This is a free template, provided by OpenRegulatory.

A preview of the template is shown below. You can download it as Word (.docx), PDF or markdown file.

The template license applies (don't remove the copyright at the bottom).

Download as:

Related Documents

The following templates are Documents or SOPs related to this template. That means that they mention this template somewhere and (most likely) contain instructions on how and when to fill it out.
Beginning of template

Post-Market Clinical Follow-Up Report (PMCFR)

This template is used to document the results of all post-market-clinical-follow-up activities conducted for the medical device.

Product

Product Name Version
(your product name) (version)

Context

For your orientation, here is some guidance documents that may further help you to fill out the template: MEDDEV Guidance 2.7/1 Rev. 4 on Clinical Evaluation MEDDEV Guidance 2.12/2 Rev. 2 on Post-Market Clinical Follow-Up

The post-market clinical follow-up report (PMCFR) is compiled at the end of a surveillance interval as specified in the post-market clinical follow-up plan (PMCFP) and serves as input for the next update of the clinical evaluation. Following Annex XIV MDR, the PMCF is conducted with the aim of:

PMCF Objectives

In this section, basically copy/paste the objectives from your PMCFP.

PMCF Methods

In this section, basically copy/paste the methods from your PMFCP.

Analysis of Clinical Data

Provide a list of your PMCF activity results. Ideally, divide it into sub-sections per actions taken and conclude if your objectives have been met.

Implications for Clinical Evaluation

Discuss if, based on the clinical data you gathered, your device delivered the anticipated benefits and fulfills the performance characteristics you claimed. For orientation: this refers to the ‘References’ section in your PMCFP.

Implications for Risk Management

Discuss if any new risks were identified or if deviations were observed regarding the assumed probability and severity of existing risks. Outline any risk mitigation measures that should be taken or revised.

Risk Measures Responsible Role Due DAte
       
       

PMCF Summary

Highlight the most relevant results and conclusions from your PMCF activities. For example: does the clinical data suggest that the overall benefit-risk-profile of your product should be updated? If things look worse than before, why can it be assumed that your product is still safe?

Update of Post-Market Clinical Follow-Up

Describe implications for PMCF activities in the next surveillance interval.


Template Copyright openregulatory.com. See template license.

Please don’t remove this notice even if you’ve modified contents of this template.

End of template

Questions?

Regulatory compliance is not rocket science.

But finding a good consultant is.

No Cookie For You Privacy Policy Imprint
No QMS on this planet will save you from creating crappy software.